2'5' Oligoadenylate analogues:synthesis, biological activities and intracellular delivery.
D000227:Adenine Nucleotides / Q000138:chemical synthesis / Q000378:metabolism / Q000494:pharmacology*; D002455:Cell Division / Q000187:drug effects; D004722:Endoribonucleases / Q000378:metabolism; D006207:Half-Life; D006367:HeLa Cells / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D008081:Liposomes / Q000008:administration & dosage; D009843:Oligoribonucleotides / Q000138:chemical synthesis / Q000378:metabolism / Q000494:pharmacology*; D014677:Pharmaceutical Vehicles; D014176:Protein Biosynthesis; D013329:Structure-Activity Relationship; D014721:Vesicular stomatitis Indiana virus / Q000187:drug effects; D014779:Virus Replication / Q000187:drug effects
D000227:Adenine Nucleotides; D008081:Liposomes; D009843:Oligoribonucleotides; D014677:Pharmaceutical Vehicles; C023505:2',5'-oligoadenylate; D004722:Endoribonucleases; C031956:2-5A-dependent ribonuclease